Riskpilot← Back to searchSign inGet full accessDoctor N AB
ABActiveOrg 5594334426Båtbyggarvägen 7General medical practice activities · NACE 8621Est. 20230 employees
Revenue 2025
SEK 290K
-36% vs 2024
EBITDA margin
87.5%
-35% vs 2024
Equity ratio
55.1%
Financial strength
Net profit 2025
SEK 147K
-35% vs 2024
| Revenue | SEK 290K | -36% |
| EBITDA | SEK 254K | -35% |
| Net profit | SEK 147K | -35% |
| Total assets | SEK 738K | +34% |
| Equity | SEK 407K | +61% |
| Employees | 0 | — |
Legal name
Doctor N AB
Org number
5594334426
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
9 maj 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård, estetisk medicin, medicinsk rådgivning, föreläsningar och utbildning. Bolaget ska bedriva estetiska behandlingar, skönhetsvård, hudvård, inköp av sjukvårdsartiklar och läkemedel, försäljning av sjukvårdsprodukter, skönhetsprodukter samt därmed förenliga produkter. Bolaget ska även bedriva författarskap. Bolaget ska vara verksamt med investering inom områdena fastigheter, handel med värdepapper samt därmed förenlig verksamhet.
Address
Båtbyggarvägen 7
Email
nathalie.adilipour@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 193 | 452 | 290 |
| Staff expenses | — | −6 | −0 |
| EBITDA | 161 | 392 | 254 |
| Depreciation & amort. | — | — | −5 |
| EBIT | 161 | 392 | 249 |
| Net financials | 0 | −11 | −0 |
| Profit before tax | 121 | 286 | 186 |
| Tax | −25 | −59 | −39 |
| Net profit | 96 | 227 | 147 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 232 | 549 | 738 |
| Equity | 121 | 252 | 407 |
| Long-term debt | 27 | 42 | 22 |
| Short-term debt | 44 | 119 | 110 |
| Total debt | 71 | 161 | 132 |
EBITDA margin
87.5%
This company
15.8%
Market median
+454% vs market
20232025
Equity ratio
55.1%
This company
38.2%
Market median
+44% vs market
20232025
Return on equity
36.1%
This company
18.4%
Market median
+96% vs market
20232025
Net profit margin
50.5%
This company
8.1%
Market median
+523% vs market
20232025
Asset turnover
0.39×
This company
1.12×
Market median
-65% vs market
20232025
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2023 | |
| Board of Directors | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doctor N AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elnaz Venus Adilipour | Deputy Board Member | 0 companies |
| Nathalie Nazanin Adilipour | Board of Directors | 0 companies |